Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)

Laure F Pittet et al. BMJ Open. .

Abstract

Introduction: BCG vaccination modulates immune responses to unrelated pathogens. This off-target effect could reduce the impact of emerging pathogens. As a readily available, inexpensive intervention that has a well-established safety profile, BCG is a good candidate for protecting healthcare workers (HCWs) and other vulnerable groups against COVID-19.

Methods and analysis: This international multicentre phase III randomised controlled trial aims to determine if BCG vaccination reduces the incidence of symptomatic and severe COVID-19 at 6 months (co-primary outcomes) compared with no BCG vaccination. We plan to randomise 10 078 HCWs from Australia, The Netherlands, Spain, the UK and Brazil in a 1:1 ratio to BCG vaccination or no BCG (control group). The participants will be followed for 1 year with questionnaires and collection of blood samples. For any episode of illness, clinical details will be collected daily, and the participant will be tested for SARS-CoV-2 infection. The secondary objectives are to determine if BCG vaccination reduces the rate, incidence, and severity of any febrile or respiratory illness (including SARS-CoV-2), as well as work absenteeism. The safety of BCG vaccination in HCWs will also be evaluated. Immunological analyses will assess changes in the immune system following vaccination, and identify factors associated with susceptibility to or protection against SARS-CoV-2 and other infections.

Ethics and dissemination: Ethical and governance approval will be obtained from participating sites. Results will be published in peer-reviewed open-access journals. The final cleaned and locked database will be deposited in a data sharing repository archiving system.

Trial registration: ClinicalTrials.gov NCT04327206.

Keywords: COVID-19; immunology; infectious diseases; microbiology; virology.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Study flow chart.
See this image and copyright information in PMC

References

    1. World Health Organisation . Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19). World Health Organisation, 2020: 40.
    1. Anderson RM, Heesterbeek H, Klinkenberg D, et al. . How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 2020;395:931–4. 10.1016/S0140-6736(20)30567-5 - DOI - PMC - PubMed
    1. Gómez-Ochoa SA, Franco OH, Rojas LZ, et al. . COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol 2021;190:161–75. 10.1093/aje/kwaa191 - DOI - PMC - PubMed
    1. Chou R, Dana T, Buckley DI, et al. . Epidemiology of and risk factors for coronavirus infection in health care workers. Ann Intern Med 2020;173:120–36. 10.7326/M20-1632 - DOI - PMC - PubMed
    1. Nguyen LH, Drew DA, Graham MS, et al. . Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health 2020;5:e475–83. 10.1016/S2468-2667(20)30164-X - DOI - PMC - PubMed

Publication types

Associated data